Related Experiment Video
Updated: May 17, 2025

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
7.4K
Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate
Tyler Walburn1, Yetkin Tuaç2, Çağdaş Aktan3
1Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
The Eurasian Journal of Medicine
|May 16, 2025
Summary
Cribriform pattern 4 (CP4) presence in high-risk prostate cancer (PC) significantly worsens progression-free survival (PFS). This finding highlights CP4
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Cribriform pattern 4 (CP4) is known to negatively impact survival in non-high-risk prostate cancer (PC).
- The prognostic value of CP4 in high-risk PC remains unclear.
Purpose of the Study:
- To investigate the association between cribriform pattern 4 and progression-free survival (PFS) in patients with high-risk prostate cancer.
- To evaluate the prognostic significance of CP4 in the context of radical prostatectomy for high-risk PC.
Main Methods:
- Retrospective analysis of individual patient data from The Cancer Genome Atlas (TCGA) database.
- Inclusion of patients who underwent radical prostatectomy for high-risk prostate cancer (Gleason score 8-10).
- Statistical analysis to assess the relationship between CP4 presence and PFS, adjusted for covariates.
Main Results:
- The study included 135 patients, with CP4 identified in 66 (48.9%).
- Median follow-up duration was 45.93 months.
- The presence of CP4 was significantly associated with reduced PFS (subdistribution hazard ratio, 1.99; P=.045) after adjusting for other factors.
Conclusions:
- Cribriform pattern 4 is a significant adverse prognostic indicator in high-risk prostate cancer (Gleason 8-10).
- The findings suggest CP4 presence portends worse progression-free survival following radical prostatectomy.
- Further research is needed to clarify the role of CP4 in risk stratification and guiding post-operative management strategies for PC.

